Tower Research Capital »

Actuate Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 1.6k 6.69
2025-06-30 $78 13 6.08
2025-03-31 $17k 2.6k 6.77
2024-09-30 $2.2k 297 7.45